MDL Panel clarifies scope of Taxotere MDL; says claims involving both generic and name-brand Taxotere allowed in litigation

SAN DIEGO, CALIF., UNITED STATES, February 23, 2017 /EINPresswire.com/ -- Taxotere hair loss lawsuits are steadily being filed in Louisiana federal court following a massive spike during the holiday season.

The Taxotere multidistrict litigation (MDL) added 50 more lawsuits between January and February, according to the Judicial Panel on Multidistrict Litigation’s MDL Statistics Report.

That’s after the MDL nearly tripled in size between December and January, jumping from just over 260 lawsuits to more than 700.

The MDL now totals 755 lawsuits as of Feb. 15 and the stream of cases is likely to continue.

The MDL Panel recently decided that the Taxotere MDL included complaints against both name-brand Taxotere and generic docetaxel.

Docetaxel is the generic name of Taxotere, a chemotherapy drug used to treat breast and other forms of cancer. The drug has been linked to permanent alopecia, a condition in which the hair does not grow back after chemotherapy treatment.

The MDL Panel clarified the scope of the Taxotere MDL in a letter written Jan. 4, 2017.

The panel explained that the litigation was intended to include cases against generic manufacturers, as well as the maker of name-brand Taxotere, Sanofi S.A.

The panel said the MDL included docetaxel in its formal title, suggesting the litigation involved complaints against both forms of the drug.

The panel’s letter was in response to District Judge Kurt D. Engelhardt, who wrote to the panel for clarification on Dec. 29, 2016.

Judge Englehardt is presiding over the Taxotere litigation, which was consolidated just four months ago in the Eastern District of Louisiana.

Taxotere lawsuits accuse Sanofi S.A. and other generic manufacturers of designing a defective drug and failing to adequately warn about its risk of causing permanent hair loss.

Taxotere patients who experienced permanent hair loss may be able to file a Taxotere Lawsuit of their own. Schmidt National Law Group is currently seeking claimants and is in the process of filing claims related to Taxotere and permanent hair loss. Contact us today at 1-800-214-1010 or visit our website to learn more.

The case is In re: Taxotere (Docetaxel) Products Liability Litigation in the U.S. District Court for the Eastern District of Louisiana.

About Schmidt National Law Group

Schmidt National Law Group is a personal injury firm located in San Diego, Calif. Its team of experienced attorneys represents victims of all types of injuries, including those harmed by pharmaceutical drugs and medical devices.

Schmidt National Law Group’s team of attorneys, medical professionals, writers, and case managers fight every day for the rights of the injured. Martin Schmidt, a trial attorney with 30 years experience, has been recognized as a leading personal injury attorney and was chosen as one of the "Top 100 Trial Lawyers" by the American Association for Justice in 2015 and 2016.

Contact Us

Schmidt National Law Group
http://www.nationalinjuryhelp.com/
4241 Jutland Drive, Suite 200, San Diego CA, 92117
(800) 214-1010

Melissa Beltz
Schmidt National Law Group
800-214-1010 Ext. 370
email us here